Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | NDI-101150 |
Trade Name | |
Synonyms | NDI 101150|NDI101150 |
Drug Descriptions |
Limited information is currently available on NDI-101150, a putative MAP4K1 (HPK1) inhibitor (Mar 2022). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
NDI-101150 | NDI-101150 | 0 | 1 |
NDI-101150 + Pembrolizumab | NDI-101150 Pembrolizumab | 0 | 1 |